Purple Biotech Ltd. (PPBT) NASDAQ
4.54
-0.4099(-8.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.54
-0.4099(-8.28%)
Currency In USD
| Market Cap | 15,768 |
| Enterprise Value | -8.46M |
| P/E Ratio | -0.12 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.33 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1.18 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.5 |
| Return On Equity | -0.99 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -204,610 |
| EBITDA | -6.83M |
| Net Income | -26.81M |
| Diluted EPS | -11,080 |
| Total Cash | 9.57M |
| Total Cash/Share | 0.01 |
| Total Debt | 243,996 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 1.27 |
| Book Value Per Share | 0.01 |
| 52-Week Change | -83.01 |
| 52-Week High | 29.4 |
| 52-Week Low | 3.6 |
| Moving Average 50 Days | 4.54 |
| Moving Average 200 Days | 9.54 |
| Average Volume | 14,318 |
| Shares Outstanding | 138,084 |
| % Held by Institutions | 0.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | March 02, 2026 |